The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of ...
The FDA has added a boxed warning to the labeling of Veozah, a medication used to treat hot flashes, highlighting a rare but serious risk of liver injury.
The labeling for the product now includes a boxed warning alerting prescribers that hepatic function should be evaluated prior to initiating treatment. Veozah should not be started in patients if ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback